AIDSACTIONBALTIMORE PREP UP TOWN HALL

Slides:



Advertisements
Similar presentations
Sexually Transmitted Disease (STD) Surveillance Report, 2010
Advertisements

HIV treatment as prevention Stephen Kegg. 2 Learning Outcomes Overview of HIV management HIV transmission risks Current prevention strategies Which new.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
TasP is not enough Stipulated that TasP is effective in reducing infectiousness of the treated person – But much more is required. TasP requires effective.
HIV Care Continuum, Men Who Have Sex with Men Only (MSMO) and Men Who Have Sex with Men and Women (MSMW), Georgia, 2012.
Late HIV Diagnoses, Georgia,
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2013 Living (Prevalence)
HIV Infection Among Those with an Injection Drug Use*- Associated Risk, Florida, 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
Monitoring the effects of ARV treatment programmes on prevention Gabriel Mwaluko 1, Mark Urassa,2, John Changalucha,2, Ties Boerma 3 1 TANESA Project,
N ORTHWEST AIDS E DUCATION AND T RAINING C ENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
HIV Care Continuum, District 8- 2 Southwest (Albany), Georgia, 2012.
Sexually Transmitted Infections Mysheika Williams Roberts, MD, MPH Medical Director Assistant Health Commissioner Columbus.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Washington D.C., USA, July 2012www.aids2012.org Equal behaviors, unequal risks: The role of partner transmission potential in racial HIV disparities.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
Anticipated Risk Compensation with Pre-Exposure Prophylaxis Use among North American Men who have Sex with Men Using an Internet Social Network D Krakower,
Implementation of HIV Treatment as Prevention in China Yan Zhao MD National Center for AIDS/STD Control & Prevention Chinese Center for Disease Control.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV Care Continuum, District 10 Northeast (Athens), Georgia, 2012.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
Sexually Transmitted Disease (STD) Surveillance Report, 2013 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
STIs (sexually transmitted infections) in the geriatric population
Sexually Transmitted Disease (STD) Surveillance Report, 2008 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
1 MSM Sexual Health Summit August 20, 2012 HIV/STD Prevention and Care Branch Texas Department of State Health Services.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014 Florida Department of Health HIV/AIDS Section Division of Disease.
The HIV Care Continuum: A Tool for Driving Systematic Change to Support Better Engagement in Care Jeffrey S. Crowley Distinguished Scholar/ Program Director.
Grinsztejn B, et al, Lancet Infect Dis, March 4 th 2014 PRIMARY COMBINED M&M OUTCOME FIRST AIDS DEFINING EVENT FIRST TB EVENT DEATH.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Viral load distribution 2012 among persons living with HIV and persons newly diagnosed Georgia, 2011.
BRADFORD BRIGGS & NIKE JACKSON. BRADFORD BRIGGS Prevention Toolbox.
American Dermatological Association September 16, 2011 Silverado Resort, Napa, California Pitfalls, Perils & Pearls.
Summary of HIV Infection in Alaska, 1982–2015 Prepared by the State of Alaska Department of Health and Social Services, Division of Public Health, HIV/STD.
Expanded PrEP implementation across Australia Expanded implementation of PrEP across Australia 1.
Expanded PrEP implementation in NSW (EPIC-NSW) 1 AIDS 2016 | 22 July 2016.
Pre-exposure Prophylaxis (PrEP) for HIV Prevention: What’s the Future? Joanne Stekler, MD MPH Assistant Professor of Medicine University of Washington.
Eliminating Barriers to Increase Uptake of PrEP in a Community- Based Clinic in San Francisco Presenting Author: Pierre-Cédric Crouch, PhD, ANP-BC, ACRN,
HIV/AIDS in Utah Edwin Espinel HIV Counseling & Testing, Partner Services Program Coordinator University of Utah May 2013 Utah Department of Health Bureau.
Cervical Cancer Awareness: HPV 101
Integrating Diagnostic Services at Point of Care
PrEP for HIV Prevention
Sex between men that occurs under the influence of Mephedrone, GHB/GBL or Crystal Meth
HIV Epidemiological Profile for Chicago EMA
Identifying the Barriers of Condom Use in College Students Arielle Zimmer, RN State University of New York Institute of Technology Department of Nursing.
A study of high risk African American women, 15 to 21 years of age
Co-infection of STIs with HIV among men who have sex with men (MSM) in Beijing, China Xiaoyan Zhang State Key Laboratory for Infectious Disease Prevention.
The Last Mile to EMTCT: Are we there yet?
David Magnuson, Trevor Hawkins, Robertino Mera
One pill a day, can keep HIV away
Pre-Exposure Prophylaxis (PrEP) for HIV Infection
Global Optimization of the Response to HIV
Health Protection Surveillance Centre
100 Partners PrEP[5] Efficacy 75% Adherence 81% 80
Health Protection Surveillance Centre
Among 3647 MSM not using SMS prior to PS interview. Bold = p<0.05.
Sexually Transmitted Infections (STIs) in Ireland, 2016
HIV, STIs and Hepatitis among men who have sex with men (MSM) in Ireland October provisional data.
HIV.
INTRODUCTION & STUDY AIMS
National HIV notifications Q – Q4 2018
Lesson 3: Treatment as Prevention
U=U Guidance for Implementation in Clinical Settings
PrEP in Brazil: 18 months of implementation as a public health policy
Undetectable = Untransmittable
Presentation transcript:

AIDSACTIONBALTIMORE PREP UP TOWN HALL PreP and Prevention IAC 2018 Update Lynda Dee September 26, 2018

PrEP UP Town Hall Meeting CDC: HIV Transmission Statistics CDC: Impact of PrEP on HIV Diagnoses 2012 to 2016 2017 TASP: Transmission in Undetectable MSM Couples PARTNER 2 Study: U=U in MSM Couples Biologic & Behavioral Risk: Before, During and After PrEP PREPARE Study: STI Incidence on PrEP vs. No PrEP Adolescents: Use of PrEP 2012-2017 New Data: HIV Prevention Strategies

PrEP UP Town Hall Meeting CDC HIV Transmission Statistics 1 in 49 in Maryland 1 in 20 in Black Men in the US 1 in 2 in Black MSM in the US

PrEP UP Town Hall Meeting CDC: PrEP Impact on HIV Diagnoses 2012-2016 HIV diagnosis declined 18% from 2008 to 2015 There will still be approx 40,000 diagnoses each year Reasons for possible diagnosis decline: Lower frequency of testing Lower sexual and needle sharing behavior Higher viral suppression in people with HIV Higher PrEP uptake for those at risk

PrEP UP Town Hall Meeting CDC: PrEP Impact on HIV Diagnoses 2012-2016 HIV testing and risk behaviors have not decreased Whether lower viral suppression and PrEP use accounts for decreased diagnoses is unknown PrEP use increased in the US from 2012 to 2015, independent of higher viral suppression US states should to take steps to increase both PrEP use and viral suppression These associations need to be studied in counties

PrEP UP Town Hall Meeting Undetectable VL & HIV Transmission in Gay Couples Opposites Attract: (TASP) Observational study in 3 countries 12,000 condom free male anal sex acts in 3/4 of couples 343 discordant couples, (one positive and one negative) Some men had other partners

PrEP UP Town Hall Meeting Undetectable VL & HIV Transmission in Gay Couples No infections in HIV partner by HIV+ partner PARTNER 1 + Opposites Attract = 34,911 condomless anal sex acts Condomless sex, with HIV+ partner who is undetectable = safe sex CAUTION: VL remains detectable in the first months after ARVs

PrEP UP Town Hall Meeting Undetectable VL & HIV Transmission in Gay Couples PARTNER 1 study in heterosexual and gay couples PARTNER 2 study: Gay couples only: HIV+ partner is on effective ART PARTNER 2 enrolled 972 gay couples (480 couples from PARTNER 1) Median condomless sex 43 times per year 76,991 sex acts without condoms during the follow-up period

PrEP UP Town Hall Meeting Undetectable VL & HIV Transmission in Gay Couples HIV was phylogenetically tested to determine origin of infection Some HIV transmission in HIV-s, but not from their HIV+ partners HIV transmission came from another person, not their partner There was zero transmission within couple infections Confirms PARTNER 1 and TASP: A couple would need to have unprotected sex for 400 years to be at risk for HIV infection

PrEP UP Town Hall Meeting PrEP Use Rising, STI Remaining Stable (SUNY) PrEP use rose from 3% to 21% in US MSM Reviewed condom use before, during and after PrEP and the STI rate to determine if STI rate would increase significantly 313 adult MSM who used PrEP during at least 1 visit Tracked condomless anal sex with a casual partner, HIV+ or status unknown partner and the probability of a rectal STI diagnosis 50% white, 2/3 had full time jobs, 50% in relationships

PrEP UP Town Hall Meeting PrEP Use Rising, STI Remaining Stable (SUNY) Average condomless sex rose from 2.79 to 7.13 during PrEP use, and fell to fell to 2.09 after PrEP use stopped Average number of receptive condomless sex acts from 0.195 to 0.944, then dropped to 0.121 after PrEP use stopped Probability of rectal STIs rose insignificantly while on PrEP, then dropped significantly after PrEP use stopped Condomless sex acts did increase, but STI rate remained stable PrEP benefit is far greater than slight risk of STI increases while on PrEP; and STI risk decreased after PrEP use stopped

PrEP UP Town Hall Meeting PREPARE Study: STI Incidence on PrEP vs. No PrEP Many young adult males do not seek healthcare Regular PrEP visits = better health care practices Healthcare utilization review through health records in Southern CA Young males (18-34) from 7-14 to 4-16, before and after PrEP use 304 PrEP users and 4,495 MSM with no PrEP use, 273,050 not MSM

PrEP UP Town Hall Meeting PREPARE Study: STI Incidence on PrEP vs. No PrEP PrEP users were older (27-34 vs. 18-26), and had more care, including more ER, primary, psychiatric and other specialty visits PrEP users had more mental health diagnoses HPV/HBV vaccinations: Low in all groups, but higher with PrEP use Higher STI and hepatitis testing in PrEP users Higher STIs and mental disorders in the PrEP group, but better primary and preventive care as well as STI screening

PrEP UP Town Hall Meeting PrEP Use in US Adolescents 15.4% PrEP use in adolescents under 24 years old 1.5% PrEP use in adolescents under 18 years old In adolescents under 18, PrEP usage was 83.5% female PrEP use in 18-24 years is 84.2% male Recent FDA indication change may improve adolescent access Important unmet need: Improve PrEP awareness and engagement

PrEP UP Town Hall Meeting New HIV Prevention Strategies (2017 IAS Meeting) Long-Acting Cabotegravir (CAB): IM injection/8wks Long-Acting Rilpivirine: Development Stopped Long-Acting Oral MK-8591: Oral every 30 days?

PrEP UP Town Hall Meeting New Prevention Strategies Broadly Neutralizing Antibodies (nNAbs) Alternative to vaccine approach Single IV infusion combo results in monkeys Single IV infusion plus SubQ results in monkeys

PrEP UP Town Hall Meeting New Prevention Strategies: (bNAbs) IV 3BNC117 + LS dmAB (11 to 23 wk infection delay) IV 10-1074 + LS dmAb (18 to 37 wk infection delay) IV 10-1074 + 3BNC117 + LS dmAB (Subq) (20 weeks) Could translate to annual or semi-annual regimens

PrEP UP Town Hall Meeting Next Town Hall Meeting Wednesday, November 28, 2018 Time 6:30 to 8:00 PM Place Waxter Center

PrEP UP Town Hall Meeting THANK YOU Gilead Sciences Baltimore City Health Department

PrEP UP Town Hall Meeting THANK YOU Johns Hopkins Reach Initiative Chase Brexton Health Care Center for Black Equity-Baltimore GLCCB Jacques Initiative Total Health Care PrEP UP: Falina Chanel, Alvin Moody, Jeffrey Grabelle, Jay Mangum